Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy

HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia

(2011) C Diong et al.   HIV MEDICINE

Biological, clinical and population relevance of 95 loci for blood lipids

(2010) Tanya M. Teslovich et al.   NATURE

Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals

(2009) Margalida Rotger et al.   Circulation-Cardiovascular Genetics

Effectiveness of lipid-lowering therapy in HIV patients

(2009) Esteban Martínez et al.   Current Opinion in HIV and AIDS

High Prevalence of Peripheral Arterial Disease in HIV-Infected Persons

(2008) D. Periard et al.   CLINICAL INFECTIOUS DISEASES

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population

(2008) Chiara Sabatti et al.   NATURE GENETICS

Common variants at 30 loci contribute to polygenic dyslipidemia

(2008) Sekar Kathiresan et al.   NATURE GENETICS

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

(2008) Yurii S Aulchenko et al.   NATURE GENETICS

Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study

(2008) Christopher J. O’Donnell et al.   REVISTA ESPANOLA DE CARDIOLOGIA